Recombinant receptors binding B cell activation factor receptor patent

Recombinant receptors binding B cell activation factor receptor patent

Ofgem Consultation on Future Interconnection Strategy

Ofgem has issued a call for input seeking views on its proposals for a future strategic approach to interconnection in Great Britain. The consultation focuses on the delivery and financing approaches for future interconnection projects identified through National Energy System Operator (NESO) strategic planning.

ASIC Corporations Amendment Instrument 2026/186

The Australian Securities and Investments Commission (ASIC) has issued the Corporations Amendment Instrument 2026/186, amending existing corporate regulations. This instrument is authorised by the Corporations Act 2001 and is effective from March 25, 2026.

ASIC Corporations (Consents to Statements) Instrument 2026/89

The Australian Securities and Investments Commission (ASIC) has issued the ASIC Corporations (Consents to Statements) Instrument 2026/89, which takes effect on March 25, 2026. This legislative instrument is authorised by the Corporations Act 2001.

ASIC Corporations (Disregarding Technical Relief) Instrument 2026/180

The Australian Securities and Investments Commission (ASIC) has issued the Corporations (Disregarding Technical Relief) Instrument 2026/180, which provides relief from certain technical requirements under the Corporations Act 2001. This instrument is administered by the Department of the Treasury and is effective from March 25, 2026.

ASIC Corporations Instrument 2026/59 - Electronic Lodgment of Financial and Sustainability Reports

The Australian Securities and Investments Commission (ASIC) has issued the Corporations Instrument 2026/59, which authorises the electronic lodgment of financial and sustainability reports. This instrument is made under the Corporations Act 2001 and takes effect on March 25, 2026.

ASIC Corporations Instrument 2026/93

The Australian Securities and Investments Commission (ASIC) has issued the ASIC Corporations Instrument 2026/93, which came into force on March 25, 2026. This instrument is authorized under the Corporations Act 2001 and relates to market research and roadshows.

ASIC Corporations Minimum Bid Price Instrument 2026/101

The Australian Securities and Investments Commission (ASIC) has issued the Corporations (Minimum Bid Price) Instrument 2026/101. This legislative instrument, authorised by the Corporations Act 2001, establishes a minimum bid price requirement.

ASIC Corporations Instrument 2026/98 - Non-Traditional Rights Issues

The Australian Securities and Investments Commission (ASIC) has issued the Corporations (Non-Traditional Rights Issues) Instrument 2026/98, which is now in force. This instrument is authorised under the Corporations Act 2001 and relates to non-traditional rights issues.

ASIC Corporations (Real Estate Companies) Instrument 2026/99

The Australian Securities and Investments Commission (ASIC) has issued the ASIC Corporations (Real Estate Companies) Instrument 2026/99. This instrument, authorised by the Corporations Act 2001, designates specific rules or exemptions for real estate companies.